Green Brick Partners, Inc. current report, 25 January 2021

Business Context and Reporting Period

Company: Green Brick Partners, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 25, 2021
Event: Entry into a Material Definitive Agreement (Underwriting Agreement).

Key Financial Metrics

This filing reports a secondary offering transaction and does not contain standard financial performance metrics such as revenue, profit, cash flow, or debt levels.

  • Shares Sold: 6,000,000 shares of Common Stock.
  • Price Per Share: $20.55.
  • Total Proceeds to Company: $0 (The Company did not sell any shares and received no proceeds).
  • Sellers: Selling Stockholders named in Schedule A to the Underwriting Agreement.
  • Underwriters: Barclays Capital Inc. and Goldman Sachs & Co. LLC.

Material Changes Versus Prior Period

The filing does not provide comparative financial data or discuss changes in operational metrics versus prior periods. The material change reported is the execution of the Underwriting Agreement for the sale of shares by existing stockholders.

Guidance, Outlook, and Risks

Management Commentary: The filing confirms the terms of the secondary offering but does not include forward-looking guidance, outlook statements, or management commentary on future performance.

Risks and Contingencies: The filing notes that the Underwriting Agreement contains customary representations, warranties, covenants, and indemnification obligations. No specific new risks or contingencies are detailed in the text of this report.

Important Facts for Investor Verification

  • Verify that the Company received no proceeds from this transaction, as it was a sale by Selling Stockholders only.
  • Confirm the identity of the Selling Stockholders in Schedule A of the Underwriting Agreement (Exhibit 1.1) to assess potential dilution or insider selling activity.
  • Review the full Underwriting Agreement (Exhibit 1.1) for specific lock-up provisions or indemnification terms.
  • Note that the offering was made pursuant to a prospectus supplement dated January 25, 2021, under a shelf registration statement (File No. 333-250977).